LabOne, Inc. Form 8-K dated July 8, 2004

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, N4R7cRUuXhoHwexbj7DPSzzHErRz6Ym6Z43deirAclh1gFI4X1WxZVgsSW77TSNH njFqUwKcRm45j+U6qYEYtA== 0000830158-04-000052.txt : 20040708 0000830158-04-000052.hdr.sgml : 20040708 20040708091237 ACCESSION NUMBER: 0000830158-04-000052 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040708 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20040708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABONE INC/ CENTRAL INDEX KEY: 0000830158 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 431039532 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-92137 FILM NUMBER: 04905193 BUSINESS ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: P. O. BOX 7568 CITY: LENEXA STATE: KS ZIP: 66219 BUSINESS PHONE: 9138881770 MAIL ADDRESS: STREET 1: 10101 RENNER BLVD STREET 2: X CITY: LENEXA STATE: KS ZIP: 66219 FORMER COMPANY: FORMER CONFORMED NAME: LAB HOLDINGS INC DATE OF NAME CHANGE: 19980406 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPITAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEAFIELD CAPTIAL CORP DATE OF NAME CHANGE: 19910520 8-K 1 addl.htm LabOne, Inc. Form 8-K dated July 8, 2004 UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: July 8, 2004

Commission file number: 0-16946

LabOne, Inc.

10101 Renner Blvd.

Lenexa, Kansas 66219

(913) 888-1770

Incorporated in Missouri

I.R.S. Employer Identification Number: 43-1039532

Item 9. Regulation FD Disclosure

LabOne Announces Exercise of Option to Purchase Additional Convertible Senior Debentures

LabOne, Inc. (Nasdaq: LABS), announced today that the initial purchasers exercised their option to purchase an additional $13.5 million principal amount of the Company's 3.50% convertible senior debentures due 2034. The Company used approximately $87 million of the initial proceeds of the offering to reduce borrowings under its credit facility. The additional proceeds of approximately $13 million will be used by the Company to pay the remaining borrowings under its credit facility and for general corporate purposes.

This report on Form 8-K does not constitute an offer to sell or the solicitation of any offer to buy any securities. The securities have not been registered under the Securities Act, or any state securities laws, and unless so registered may not be offered or sold in the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

LabOne, Inc.

Date: July 8, 2004

By /s/ John W. McCarty
John W. McCarty
Executive V.P. and Chief Financial Officer

-----END PRIVACY-ENHANCED MESSAGE-----